-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalyn presents AP01 eFlow nebulizer usability study data at ATS 2026

PUBT·05/05/2026 20:03:01
Listen to the news
Avalyn presents AP01 eFlow nebulizer usability study data at ATS 2026
  • Avalyn Pharma flagged new patient-centered research on AP01 delivery and supportive care experiences, with results scheduled for presentation at American Thoracic Society 2026 International Conference in Orlando on May 18, 2026.
  • A usability study of eFlow nebulizer system for inhaled pirfenidone AP01 found patient, care partner, clinician feedback helped refine instructions intended to improve real-world use.
  • Separate research on idiopathic pulmonary fibrosis supportive care highlighted patient demand for faster, clearer communication, stronger care partner involvement, better access to specialist expertise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605051601PRIMZONEFULLFEED9713559) on May 05, 2026, and is solely responsible for the information contained therein.